4,895
Views
4
CrossRef citations to date
0
Altmetric
Review

Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices

Pages 325-335 | Received 19 Sep 2021, Accepted 20 Dec 2021, Published online: 23 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Isabella Ballalai, Rob Dawson, Michael Horn, Vinny Smith, Rafik Bekkat-Berkani, Lamine Soumahoro & Nevena Vicic. (2023) Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions. Expert Review of Vaccines 22:1, pages 457-467.
Read now
Véronique Abitbol, Woo-Yun Sohn, Michael Horn & Marco Aurelio P. Safadi. (2023) Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review. Human Vaccines & Immunotherapeutics 19:2.
Read now
Muhamed-Kheir Taha, Rafik Bekkat-Berkani & Véronique Abitbol. (2023) Changing patterns of invasive meningococcal disease and future immunization strategies. Human Vaccines & Immunotherapeutics 19:1.
Read now

Articles from other publishers (1)

Ola Brønstad Brynildsrud, Sara Viksmoen Watle, Kristian Alfsnes & Dominique A. Caugant. (2023) Invasive meningococcal disease in Norway in the two decades before the COVID-19 pandemic. International Journal of Infectious Diseases 131, pages 130-139.
Crossref